Status:

COMPLETED

Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Fungal Infections

Eligibility:

All Genders

Brief Summary

This study will examine the safety and efficacy of posaconazole in general use in Korea. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will ...

Eligibility Criteria

Inclusion

  • Treated with posaconazole oral suspension within current local label

Exclusion

  • Contraindication to posaconazole oral suspension according to current local label

Key Trial Info

Start Date :

February 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

273 Patients enrolled

Trial Details

Trial ID

NCT01436578

Start Date

February 1 2012

End Date

November 1 2013

Last Update

July 7 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.